# Quality of Life and Adverse Effects in Epilepsy Patients (EPIKA)

> **NCT00302991** · — · COMPLETED · sponsor: **UCB Pharma** · enrollment: 180 (—)

## Conditions studied

- Epilepsy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00302991
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 180 (—)
- **Last updated:** 2008-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00302991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00302991, "Quality of Life and Adverse Effects in Epilepsy Patients (EPIKA)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00302991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*